Home
About
Overview
Sharing Data
ORCID
Help
History (6)
c-Met inhibition.
Hudalla, Gregory
Inhibiting substance p pathway for prevention of chemotherapy-induced emesis: preclinical data, clinical trials of neurokinin-1 receptor antagonists.
Trace Elements
Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance.
See All 6 Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance.
Tumor progression locus 2 (TPL2) regulates obesity-associated inflammation and insulin resistance. Diabetes. 2011 Apr; 60(4):1168-76.
View in:
PubMed
subject areas
Adipose Tissue
Animals
Blotting, Western
Bone Marrow Cells
Cells, Cultured
Dietary Fats
Fatty Liver
Female
Humans
Immunohistochemistry
Inflammation
Insulin Resistance
JNK Mitogen-Activated Protein Kinases
Liver
Macrophages
Male
MAP Kinase Kinase Kinases
Mice
Mice, Knockout
Obesity
Proto-Oncogene Proteins
Reverse Transcriptase Polymerase Chain Reaction
Triglycerides
authors with profiles
Eugene B. Chang